[HTML][HTML] Identification of gene signature as diagnostic and prognostic blood biomarker for early hepatocellular carcinoma using integrated cross-species transcriptomic …
Background: Hepatocellular carcinoma (HCC) is considered the most common type of liver
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …
[引用][C] 1. Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species …
O Al-Harazi - spandidos-publications.com
Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic …
O Al-Harazi, IH Kaya, M Al-Eid… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background: Hepatocellular carcinoma (HCC) is considered the most common type of liver
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …
[HTML][HTML] Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species …
O Al-Harazi, IH Kaya, M Al-Eid, L Alfantoukh… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Background: Hepatocellular carcinoma (HCC) is considered the most common type of liver
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …
Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic …
O Al-Harazi, IH Kaya, M Al-Eid, L Alfantoukh… - Frontiers in …, 2021 - europepmc.org
Background: Hepatocellular carcinoma (HCC) is considered the most common type of liver
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …
Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic …
O Al-Harazi, IH Kaya, M Al-Eid… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background: Hepatocellular carcinoma (HCC) is considered the most common type of liver
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …
Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic …
O Al-Harazi, IH Kaya, M Al-Eid, L Alfantoukh… - Frontiers in …, 2021 - europepmc.org
Background: Hepatocellular carcinoma (HCC) is considered the most common type of liver
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …
cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease …